Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GH Guardant Health Inc.

未开盘 08-11 16:00:00 EDT

54.80

+0.57

+1.05%

盘后53.74

-1.06-1.93%

19:24 EDT

最高55.10	最低53.29	成交量209.11万
今开54.61	昨收54.23	日振幅3.34%
总市值68.34亿	流通市值65.52亿	总股本1.25亿
成交额1.13亿	换手率1.75%	流通股本1.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GH","market":"US","secType":"STK","nameCN":"Guardant Health Inc.","latestPrice":54.8,"timestamp":1754942400000,"preClose":54.23,"halted":0,"volume":2091058,"hourTrading":{"tag":"盘后","latestPrice":53.74,"preClose":54.8,"latestTime":"19:24 EDT","volume":93885,"amount":5144425.8504,"timestamp":1754954681237},"delay":0,"floatShares":119553746,"shares":124705857,"eps":-3.345294,"marketStatus":"未开盘","change":0.57,"latestTime":"08-11 16:00:00 EDT","open":54.61,"high":55.1,"low":53.29,"amount":113387417.217374,"amplitude":0.033376,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.345294,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1754985600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":54.23,"preHourTrading":{"tag":"盘前","latestPrice":54.8701,"preClose":54.23,"latestTime":"09:25 EDT","volume":3275,"amount":178458.26734999998,"timestamp":1754918700441},"postHourTrading":{"tag":"盘后","latestPrice":53.74,"preClose":54.8,"latestTime":"19:24 EDT","volume":93885,"amount":5144425.8504,"timestamp":1754954681237},"volumeRatio":0.484138,"impliedVol":0.4604,"impliedVolPercentile":0.036},"requestUrl":"/m/hq/s/GH/wiki","defaultTab":"wiki","newsList":[{"id":"2557578822","title":"Guardant Health, Inc.盘中异动 股价大涨5.00%报52.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557578822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557578822?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:35","pubTimestamp":1754660138,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时35分，Guardant Health, Inc.股票出现异动，股价大幅拉升5.00%。Guardant Health, Inc.股票所在的生命科学行业中，整体涨幅为0.30%。其相关个股中，Sotera Health Company、Natera, Inc.、Endra Life Sciences Inc.涨幅较大，Endra Life Sciences Inc.、Ispecimen Inc.、Advanced Biomed Inc.较为活跃，换手率分别为60.95%、11.96%、1.82%，振幅较大的相关个股有Ispecimen Inc.、Biodesix, Inc.、Endra Life Sciences Inc.，振幅分别为11.67%、8.48%、6.51%。Guardant Health, Inc.公司简介：Guardant Health, Inc总部位于加州红木城，是临床和研究用液体癌症检测的领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213539a6db222c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","BK4588","CRC","BK4535","BK4213","LU0266512127.USD","LU0456854461.SGD","BK4551","BK4585","GH"],"gpt_icon":0},{"id":"2557552069","title":"GH Research Q2 EPS $(0.15) Beats $(0.21) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557552069","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557552069?lang=zh_cn&edition=full","pubTime":"2025-08-07 19:15","pubTimestamp":1754565312,"startTime":"0","endTime":"0","summary":"GH Research (NASDAQ:GHRS) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.21) by 30.23 percent. This is a 25 percent increase over losses of $(0.20) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"GH Research第二季度EPS$(0.15)超出预期$(0.21)","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46957749/gh-research-q2-eps-0-15-beats-0-21-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GHRS","GH"],"gpt_icon":0},{"id":"2557870309","title":"Guardant Health, Inc.盘中异动 股价大跌5.11%报43.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557870309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557870309?lang=zh_cn&edition=full","pubTime":"2025-08-07 00:41","pubTimestamp":1754498487,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日00时41分，Guardant Health, Inc.股票出现波动，股价快速下挫5.11%。截至发稿，该股报43.81美元/股，成交量92.7359万股，换手率0.74%，振幅5.40%。Guardant Health, Inc.股票所在的生命科学行业中，整体跌幅为1.75%。Guardant Health, Inc.公司简介：Guardant Health, Inc总部位于加州红木城，是临床和研究用液体癌症检测的领导者。2021年，Guardant推出了Reveal，这是一种与肿瘤无关的分子残留疾病测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807004127a4791eef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BK4585","LU0266512127.USD","BK4588","BK4535","CRC","LU0456854461.SGD","GH","BK4196","BK4213"],"gpt_icon":0},{"id":"2557353603","title":"Guardant Health, Inc.盘中异动 下午盘股价大涨5.02%报43.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557353603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557353603?lang=zh_cn&edition=full","pubTime":"2025-08-05 01:13","pubTimestamp":1754327604,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日01时13分，Guardant Health, Inc.股票出现波动，股价快速拉升5.02%。截至发稿，该股报43.50美元/股，成交量90.4446万股，换手率0.73%，振幅5.53%。Guardant Health, Inc.股票所在的生命科学行业中，整体涨幅为3.64%。Guardant Health, Inc.公司简介：Guardant Health, Inc总部位于加州红木城，是临床和研究用液体癌症检测的领导者。2021年，Guardant推出了Reveal，这是一种与肿瘤无关的分子残留疾病测试。此外，Guardant还提供研发服务，如监管审批咨询和临床试验推荐。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805011324a6d2ca30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","BK4196","LU0456854461.SGD","LU0266512127.USD","CRC","BK4585","GH","BK4588","BK4535","BK4551"],"gpt_icon":0},{"id":"2556878251","title":"Guardant Health, Inc.2025财年第二财季实现净利润-99.90百万美元，同比增加3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556878251","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556878251?lang=zh_cn&edition=full","pubTime":"2025-08-04 00:01","pubTimestamp":1754236871,"startTime":"0","endTime":"0","summary":"8月4日，Guardant Health, Inc.公布财报，公告显示公司2025财年第二财季净利润为-99.90百万美元，同比增加3.01%；其中营业收入为2.32亿美元，同比增加31.07%，每股基本收益为-0.80美元。机构评级：截至2025年8月4日，当前有22家机构对Guardant Health, Inc.目标价做出预测，其中目标均价为60.05美元，其中最低目标价为20.00美元，最高目标价为70.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804000247a6d0b6df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GH"],"gpt_icon":0},{"id":"1170698179","title":"异动解读 | Guardant Health盘后大涨5.66%，延续日内涨势","url":"https://stock-news.laohu8.com/highlight/detail?id=1170698179","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170698179?lang=zh_cn&edition=full","pubTime":"2025-07-31 04:37","pubTimestamp":1753907828,"startTime":"0","endTime":"0","summary":"生命科学公司Guardant Health今日盘后股价大涨5.66%，延续了日内的强劲表现。该公司在常规交易时段已经上涨了5.10%，显示出投资者对该公司的持续看好。Guardant Health是临床和研究用液体癌症检测领域的领军企业，主要提供Guardant360 LDT、Guardant360 CDx等多种液体活检产品。机构投资者对Guardant Health的前景保持乐观态度。在27家参与评级的机构中，高达85%的券商给予买入建议，11%建议持有，仅4%建议卖出。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1194705807","title":"异动解读 | Guardant Health股价盘后大涨5.66%，机构看好液体活检领域前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1194705807","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194705807?lang=zh_cn&edition=full","pubTime":"2025-07-31 04:37","pubTimestamp":1753907823,"startTime":"0","endTime":"0","summary":"生命科学公司Guardant Health今日股价表现强劲，盘后继续上涨5.66%。该公司作为临床和研究用液体癌症检测领域的领军企业，其股价走势引起了市场广泛关注。Guardant Health主要提供Guardant360 LDT、Guardant360 CDx等多种液体活检产品。公司于2024年获得美国FDA对其结直肠癌筛查产品Shield的批准，进一步巩固了其在液体活检市场的地位。值得注意的是，Guardant Health所在的生命科学行业整体涨幅为0.12%，而该公司的涨幅明显高于行业平均水平。盘中交易数据显示，公司股票成交量达176.193万股，换手率为1.42%。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"2555217000","title":"Guardant Health Q2 Adj. EPS $(0.44) Beats $(0.79) Estimate, Sales $232.09M Beat $211.26M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2555217000","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555217000?lang=zh_cn&edition=full","pubTime":"2025-07-31 04:09","pubTimestamp":1753906190,"startTime":"0","endTime":"0","summary":"Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.79) by 44.51 percent. This is a 8.33 percent increase over losses of $(0.48) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"Guardant Health第二季度调整后每股收益(0.44)美元超出预期(0.79)美元，销售额2.3209亿美元超出预期2.1126亿美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/07/46737693/guardant-health-q2-adj-eps-0-44-beats-0-79-estimate-sales-232-09m-beat-211-26m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"gpt_icon":0},{"id":"1109457299","title":"异动解读 | Guardant Health股价盘中大涨5.10%，机构普遍看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1109457299","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109457299?lang=zh_cn&edition=full","pubTime":"2025-07-31 01:42","pubTimestamp":1753897350,"startTime":"0","endTime":"0","summary":"据市场报告，生命科学公司Guardant Health今日股价表现抢眼，盘中大涨5.10%。截至发稿时，该公司股价报45.49美元/股，成交量达176.193万股，换手率为1.42%。Guardant Health是临床和研究用液体癌症检测领域的领军企业。公司主要提供Guardant360 LDT、Guardant360 CDx等多种液体活检产品，并于2024年获得美国FDA对其结直肠癌筛查产品Shield的批准。值得注意的是，Guardant Health所在的生命科学行业整体涨幅为0.12%，而该公司的涨幅明显高于行业平均水平。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"2555026377","title":"Guardant Health, Inc.盘中异动 股价大涨5.01%报45.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555026377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555026377?lang=zh_cn&edition=full","pubTime":"2025-07-31 01:33","pubTimestamp":1753896813,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日01时33分，Guardant Health, Inc.股票出现异动，股价快速上涨5.01%。截至发稿，该股报45.49美元/股，成交量176.193万股，换手率1.42%，振幅4.43%。Guardant Health, Inc.股票所在的生命科学行业中，整体涨幅为0.12%。Guardant Health, Inc.公司简介：Guardant Health, Inc总部位于加州红木城，是临床和研究用液体癌症检测的领导者。2021年，Guardant推出了Reveal，这是一种与肿瘤无关的分子残留疾病测试。此外，Guardant还提供研发服务，如监管审批咨询和临床试验推荐。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073101333397283f20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","GH","BK4196","BK4213","BK4585","BK4551","CRC","LU0456854461.SGD","BK4588","LU0266512127.USD"],"gpt_icon":0},{"id":"2546777712","title":"刚刚加盟深圳医科院的丹扬团队，在国际顶刊Cell发文","url":"https://stock-news.laohu8.com/highlight/detail?id=2546777712","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546777712?lang=zh_cn&edition=full","pubTime":"2025-06-28 19:18","pubTimestamp":1751109480,"startTime":"0","endTime":"0","summary":"6月24日，美国国家科学院院士、美国艺术与科学院院士丹扬团队在国际顶尖学术期刊Cell上发表了题为：Neuroendocrine circuit for sleep-dependent growth hormone release 的研究论文。丹扬随后，5月26日，深圳医学科学院方面发布的深圳医学科学院睡眠与意识课题组招聘公告透露，该课题组负责人为美国国家科学院院士、美国艺术与科学院院士丹扬，她将于2025年6月全职加盟深圳医学科学院，担任资深研究员。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2025-06-28/doc-infcrsei1924338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4166","GH","BK4551","BK4535","BK4588","BK4077","SST","BK4196","LC","BK4585"],"gpt_icon":0},{"id":"2546274211","title":"Guardant Health, Inc.盘中异动 早盘快速上涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546274211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546274211?lang=zh_cn&edition=full","pubTime":"2025-06-27 22:32","pubTimestamp":1751034756,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日22时32分，Guardant Health, Inc.股票出现异动，股价急速上涨5.41%。Guardant Health, Inc.股票所在的生命科学行业中，整体涨幅为0.39%。其相关个股中，Applied Dna Sciences, Inc.、Prophase Labs, Inc.、精密科学涨幅较大，Bioaffinity Technologies, Inc.、Applied Dna Sciences, Inc.、Xwell, Inc.较为活跃，换手率分别为14.89%、4.87%、1.51%，振幅较大的相关个股有Bioaffinity Technologies, Inc.、Genedx Holdings Corp C/Wts 22/07/2026 、精密科学，振幅分别为15.28%、13.30%、11.75%。Guardant Health, Inc.公司简介：Guardant Health, Inc总部位于加州红木城，是临床和研究用液体癌症检测的领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506272232369791809a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","GH","LU0266512127.USD","BK4196","BK4585","BK4588","BK4535","LU0456854461.SGD","CRC","BK4213"],"gpt_icon":0},{"id":"2545339772","title":"Guardant Health, Inc.盘中异动 早盘股价大涨5.01%报50.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545339772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545339772?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:40","pubTimestamp":1750772452,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时40分，Guardant Health, Inc.股票出现异动，股价大幅拉升5.01%。Guardant Health, Inc.股票所在的生命科学行业中，整体涨幅为0.74%。其相关个股中，Genedx Holdings Corp C/Wts 22/07/2026 、Prenetics Global、Guardant Health, Inc.涨幅较大，Bioaffinity Technologies, Inc.、Genedx Holdings Corp.、Applied Dna Sciences, Inc.较为活跃，换手率分别为1.22%、0.70%、0.26%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Prenetics Global、Exagen Inc.，振幅分别为19.23%、7.52%、6.89%。Guardant Health, Inc.公司简介：Guardant Health, Inc总部位于加州红木城，是临床和研究用液体癌症检测的领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624214052a71b583b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4196","BK4535","CRC","LU0266512127.USD","BK4551","BK4588","GH","LU0456854461.SGD","BK4213"],"gpt_icon":0},{"id":"2545741651","title":"GH Research Submits Complete Response to FDA for Depression Treatment GH001; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2545741651","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545741651?lang=zh_cn&edition=full","pubTime":"2025-06-21 01:27","pubTimestamp":1750440439,"startTime":"0","endTime":"0","summary":"GH Research  said Friday that it submitted a complete response to the US Food and Drug Administration for an investigational new drug application for GH001, its lead product candidate which is being developed as a medication for individuals with treatment-resistant depression.The regulator previously placed the application on clinical hold, according to the company.Shares of the biopharmaceutical company were up 2.1% in recent trading.Price: 12.09, Change: +0.25, Percent Change: +2.07","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"GH Research向FDA提交抑郁症治疗GH001的完整响应；股价上涨","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4196","BK4551","BK4539","BK4585","BK4007","GH","BK4535","GHRS"],"gpt_icon":0},{"id":"2543716631","title":"瑞穗银行：维持Guardant Health评级，由优于大市调整至优于大市评级, 目标价由60.00美元调整至65.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2543716631","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543716631?lang=zh_cn&edition=full","pubTime":"2025-06-14 01:48","pubTimestamp":1749836933,"startTime":"0","endTime":"0","summary":"瑞穗银行：维持Guardant Health(GH.US)评级，由优于大市调整至优于大市评级, 目标价由60.00美元调整至65.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614015243977e8a1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GH"],"gpt_icon":0},{"id":"2537931735","title":"Guardant Health, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537931735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537931735?lang=zh_cn&edition=full","pubTime":"2025-05-21 22:30","pubTimestamp":1747837807,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日22时30分，Guardant Health, Inc.股票出现波动，股价快速跳水5.00%。Guardant Health, Inc.股票所在的生命科学行业中，整体跌幅为2.30%。Guardant Health, Inc.公司简介：Guardant Health, Inc 总部位于加利福尼亚州雷德伍德城，是液体癌症检测领域的领先者，用于临床和研究用途。此外，Guardant还提供研究开发服务，如监管批准咨询和临床试验转诊。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052122300794fe1143&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","BK4535","BDSX","GH","BK4588","BK4585","BK4196","BK4213","CRC","BK4551","LU0266512127.USD"],"gpt_icon":0},{"id":"2536610154","title":"Guardant Health推出遗传性癌症检测，以识别某些类型癌症的遗传易感性Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2536610154","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536610154?lang=zh_cn&edition=full","pubTime":"2025-05-20 20:39","pubTimestamp":1747744740,"startTime":"0","endTime":"0","summary":"New Guardant Hereditary Cancer test offers germline testing to identify guideline-recommended genetic variants associated with cancer risk across 12+ tumor types新Guardant遗传性癌症测试提供生殖系测试，以识别与12种以上肿瘤类型相关的指南推荐的遗传变异。Results help guide treatment decisions and enable healthcare providers to assess patient risk for secondary cancers结果有助于指导治疗决策，并使医疗保健提供者能够评估患者继发性癌症的风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052020421894fcb8cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","BK4588","BK4535","BK4551","BK4585","GH"],"gpt_icon":0},{"id":"2534150736","title":"Guardant Health, Inc.盘中异动 急速拉升5.03%报41.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534150736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534150736?lang=zh_cn&edition=full","pubTime":"2025-05-09 02:25","pubTimestamp":1746728739,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日02时25分，Guardant Health, Inc.股票出现波动，股价急速上涨5.03%。Guardant Health, Inc.股票所在的生命科学行业中，整体涨幅为0.55%。Guardant Health, Inc.公司简介：Guardant Health, Inc 总部位于加利福尼亚州雷德伍德城，是液体癌症检测领域的领先者，用于临床和研究用途。此外，Guardant还提供研究开发服务，如监管批准咨询和临床试验转诊。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050902253997538073&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0266512127.USD","BK4213","BK4535","BK4585","BK4196","GH","LU0456854461.SGD","BK4551","BK4588","CRC"],"gpt_icon":0},{"id":"2533186327","title":"GH Research Q1 EPS $(0.19) Beats $(0.39) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533186327","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533186327?lang=zh_cn&edition=full","pubTime":"2025-05-08 19:30","pubTimestamp":1746703850,"startTime":"0","endTime":"0","summary":"GH Research (NASDAQ:GHRS) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.39) by 51.28 percent. This is a 26.67 percent decrease over losses of $(0.15) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"GH Research第一季度EPS$(0.19)超出预期$(0.39)","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45282045/gh-research-q1-eps-0-19-beats-0-39-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","GHRS"],"gpt_icon":0},{"id":"2533532958","title":"Guardant Health, Inc.2025财年第一财季实现净利润-95.16百万美元，同比增加17.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533532958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533532958?lang=zh_cn&edition=full","pubTime":"2025-05-06 00:00","pubTimestamp":1746460841,"startTime":"0","endTime":"0","summary":"5月6日，Guardant Health, Inc.公布财报，公告显示公司2025财年第一财季净利润为-95.16百万美元，同比增加17.25%；其中营业收入为2.03亿美元，同比增加20.83%，每股基本收益为-0.77美元。从资产负债表来看，Guardant Health, Inc.总负债15.95亿美元，其中短期债务29.67百万美元，资产负债比为0.85，流动比率为4.11。机构评级：截至2025年5月6日，当前有22家机构对Guardant Health, Inc.目标价做出预测，其中目标均价为58.18美元，其中最低目标价为20.00美元，最高目标价为70.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506000052a472f2fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.guardanthealth.com","stockEarnings":[{"period":"1week","weight":0.2401},{"period":"1month","weight":0.0905},{"period":"3month","weight":0.325},{"period":"6month","weight":0.2076},{"period":"1year","weight":0.8897},{"period":"ytd","weight":0.7938}],"compareEarnings":[{"period":"1week","weight":0.0075},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0836},{"period":"6month","weight":0.054},{"period":"1year","weight":0.1931},{"period":"ytd","weight":0.085}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Guardant Health, Inc.于2011年12月在特拉华州注册成立。该公司是一家领先的精密肿瘤学公司，致力于通过使用其专有血液测试，大量数据集和高级分析来帮助全球征服癌症。Guardant Health, Inc.认为征服癌症的关键是在疾病的所有阶段前所未有地获取其分子信息，他们打算通过常规抽血或液体活检来实现。Guardant Health Guardant Health Oncology Platform旨在利用其在技术，临床开发，监管和报销方面的能力来推动商业应用，改善患者临床结果并降低医疗成本。为了实现他们在疾病的各个阶段管理癌症的目标，该公司已经开展了他们的液体活检测试，Guardant360和GuardantOMNI，用于治疗晚期癌症，为公司开展复发和早期检测测试的程序提供动力，分别为LUNAR-1和LUNAR- 2。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.064605},{"month":2,"riseRate":0.285714,"avgChangeRate":0.06426},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.023739},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.017651},{"month":5,"riseRate":0.571429,"avgChangeRate":0.065461},{"month":6,"riseRate":0.714286,"avgChangeRate":0.081894},{"month":7,"riseRate":0.714286,"avgChangeRate":0.051469},{"month":8,"riseRate":0.571429,"avgChangeRate":0.039467},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.064584},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.046039},{"month":11,"riseRate":0.714286,"avgChangeRate":0.125409},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.067723}],"exchange":"NASDAQ","name":"Guardant Health Inc.","nameEN":"Guardant Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Guardant Health Inc.(GH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Guardant Health Inc.,GH,Guardant Health Inc.股票,Guardant Health Inc.股票老虎,Guardant Health Inc.股票老虎国际,Guardant Health Inc.行情,Guardant Health Inc.股票行情,Guardant Health Inc.股价,Guardant Health Inc.股市,Guardant Health Inc.股票价格,Guardant Health Inc.股票交易,Guardant Health Inc.股票购买,Guardant Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Guardant Health Inc.(GH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}